ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,841Medicare Part D Prescriptions Filled, Including Refills

Rank: 308 out of 2456

$494K Total Retail Price of All Prescriptions

Rank: 238 out of 2456

446 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 530 512 1 1
SIMVASTATIN 504 490 2 2
AMLODIPINE BESYLATE 313 301 3 5
ATENOLOL 308 297 4 6
NAMENDA 237 237 5 42
LEVOTHYROXINE SODIUM 226 213 6 4
METOPROLOL TARTRATE 221 217 7 10
OMEPRAZOLE 217 199 8 3
WARFARIN SODIUM 205 205 9 9
PRAVASTATIN SODIUM 189 186 10 15
FUROSEMIDE 180 174 11 8
HYDROCHLOROTHIAZIDE 168 155 12 7
DONEPEZIL HCL 141 141 13 23
ATORVASTATIN CALCIUM 132 108 14 12
METFORMIN HCL 120 109 15 11
METOPROLOL SUCCINATE 119 119 16 13
PREDNISONE 102 102 17 39
LOSARTAN POTASSIUM 97 97 18 18
ISOSORBIDE MONONITRATE ER 95 94 19 48
ALLOPURINOL 94 94 20 27
PAROXETINE HCL 80 74 21 56
LABETALOL HCL 75 66 22 128
LORAZEPAM 75 75 22 67
TERAZOSIN HCL 75 75 22 76
ALENDRONATE SODIUM 74 61 25 19
DIOVAN 69 68 26 26
GABAPENTIN 61 48 27 16
PANTOPRAZOLE SODIUM 61 61 27 37
TAMSULOSIN HCL 59 55 29 32
TRAMADOL HCL 59 47 29 24
EVISTA 53 53 31 143
NIFEDIAC CC 52 52 32 175
OXYCODONE-ACETAMINOPHEN 51 42 S2 33 35
CRESTOR 51 46 33 25
NIFEDIPINE ER 51 47 33 61
KLOR-CON M20 50 50 36 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.